Treatment of stage IIIb/IV non-small cell lung cancer with Pemetrexed plus Oxaliplatin after failure of Erlotinib as second-line treatment

Por Shi, Sheng-Bin, Hu, Rong-Hang, Qi, Jie-Lin, Tang, Xiao-Yong, Tian, Jing, Li, Rui, Chang, Chun-Xiao
Publicado em 2013